The University of Oxford says it will continue its COVID-19 vaccine trial in Brazil, following the death of a volunteer.
The Brazilian health authority said on Wednesday a volunteer in the clinical trial of the potential vaccine – which has been licenced to pharmaceutical giant AstraZeneca – had died.
But the university said an independent review had revealed no safety concerns.
“Following careful assessment of this case in Brazil, there have been no concerns about safety of the clinical trial and the independent review in addition to the Brazilian regulator have recommended that the trial should continue,” a spokesman said.
Sky News has approached AstraZeneca for comment.
Source : Sky News